Ecstasy and other club drugs: A review of recent epidemiologic studies

Current Opinion in Psychiatry

Volumn 21, Issue 3, 2008, Pages 234-241

  Leung, Kit Sang ^a   Cottler, Linda B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3,4 methylenedioxy N methylamphetamine; Addiction; Club drugs; Ecstasy; Epidemiology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; KETAMINE; LYSERGIDE; METHAMPHETAMINE; TRANQUILIZER;

ANXIETY DISORDER; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG CLASSIFICATION; DRUG DEPENDENCE; DRUG USE; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; HEALTH SURVEY; HEREDITY; HUMAN; MEDICAL RESEARCH; POSTTRAUMATIC STRESS DISORDER; REVIEW; SOCIAL ASPECT;

AUSTRALIA; COSTA RICA; GREAT BRITAIN; GUATEMALA; HONG KONG; HUMANS; ISRAEL; ITALY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PANAMA; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SWEDEN; TAIWAN; UNITED STATES;

EID: 41749115516     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3282f9b1f1     Document Type: Review

References (44)

1. Cottler LB, Womack SB, Compton WM, Ben Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 2001; 16:599-606.
2. Cottler LB, Ben Abdallah, Inciardi, J, Copeland, J. Use, abuse and dependence on club drugs in Sydney, St. Louis and Miami. Paper presented at the 2006 World Psychiatric Association International Congress; 12-16 July 2006; Istanbul, Turkey (in press).
3. Yen CF, Hsu SY. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents. J Nerv Ment Dis 2007; 195:866-869. This study is among the few that focus on the clinical features of MDMA use disorders. Specifically, this paper provides additional evidence for MDMA withdrawal.
4. Yacoubian GS Jr, Peters RJ. An exploration of recent club drug use among rave attendees. J Drug Educ 2007; 37:145-161.
5. Stone AL, Storr CL, Anthony JC. Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence. Int J Methods Psychiatr Res 2006; 15:116-130. Using latent class analysis, these authors show that there is a rapid development of hallucinogen dependence syndrome among young hallucinogen users who reported the initiation of hallucinogen use in the past 24 months prior to the interview. More importantly, MDMA users have been found to be more at risk in developing dependence than LSD users.
6. Carroll ME. PCP and hallucinogens. Adv Alcohol Subst Abuse 1990; 9:167-190.
7. Schuster P, Lieb R, Lamertz C, Wittchen HU. Is the use of ecstasy and hallucinogens increasing? Results from a community study. Eur Addict Res 1998; 4:75-82.
8. Degenhardt L, Dunn M. The epidemiology of GHB and ketamine use in an Australian household survey. Int J Drug Policy 2007; 5 October [Epub ahead of print].
9. Norris TF, Eyeson-Annan ML. Recent substance use and high levels of psychological distress among secondary school students in New South Wales. N S W Public Health Bull 2007; 18:125-129.
10. Bellis MA, Hughes KE, Dillon P, et al. Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents. BMC Public Health 2007; 7:1.
11. Ruan Y, Li D, Li X, et al. Relationship between syphilis and HIV infections among men who have sex with men in Beijing, China. Sex Transm Dis 2007; 34:592-597.
12. Lau JT, Tsui HY, Lam LT, Lau M. Cross-boundary substance uses among Hong Kong Chinese young adults. J Urban Health 2007; 84:704-721. This study describes a new method that can be used to conduct interviews on sensitive issues in public places. The authors have utilized this method to explore various aspects of cross-boundary drug use among 6528 adults.
13. Isralowitz RE, Reznik A. Former Soviet Union immigrant and native-born adolescents in Israel: substance use and related problem behavior. J Ethn Subst Abuse 2007; 6:131-138.
14. Wish ED, Fitzelle DB, O'Grady KE, et al. Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health 2006; 55:99-104.
15. Kliewer W, Murrelle L. Risk and protective factors for adolescent substance use: findings from a study in selected Central American countries. J Adolesc Health 2007; 40:448-455.
16. Byqvist S. Patterns of drug use among drug misusers in Sweden: gender differences. Subst Use Misuse 2006; 41:1817-1835.
17. Yen CF, Cheng CP, Tsai JL, Hsu SY. Family, peer and individual factors related to methylenedioxymethamphetamine use in Taiwanese adolescents. Psychiatry Clin Neurosci 2007; 61:552-557.
18. Yen CF, Hsu SY, Cheng CP. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan. Addict Behav 2007; 32:2286-2291.
19. Sumnall HR, Woolfall K, Edwards S, et al. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend 2008; 92:286-290.
20. Kipke MD, Weiss G, Ramirez M, et al. Club drug use in Los Angeles among young men who have sex with men. Subst Use Misuse 2007; 42:1723-1743.
21. Grov C, Bimbi DS, Nanin JE, Parsons JT. Exploring racial and ethnic differences in recreational drug use among gay and bisexual men in New York City and Los Angeles. J Drug Educ 2006; 36:105-123.
22. Halkitis PN, Palamar JJ, Mukherjee PP. Poly-club-drug use among gay and bisexual men: a longitudinal analysis. Drug Alcohol Depend 2007; 89:153-160.
23. Halkitis PN, Jerome RC. A comparative analysis of methamphetamine use: black gay and bisexual men in relation to men of other races. Addict Behav 2008; 33:83-93.
24. Parsons JT, Kelly BC, Wells BE. Differences in club drug use between heterosexual and lesbian/bisexual females. Addict Behav 2006; 31:2344-2349.
25. Kim SY, Anderson IB, Dyer JE, et al. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users. Am J Drug Alcohol Abuse 2007; 33:429-438.
26. Lankenau SE, Sanders B. Patterns of ketamine use among young injection drug users. J Psychoactive Drugs 2007; 39:21-29.
27. Lankenau SE, Sanders B, Bloom JJ, et al. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend 2007; 87:183-193.
28. Durdle H, Lundahl LH, Johanson CE, Tancer M. Major depression: the relative contribution of gender, MDMA, and cannabis use. Depress Anxiety 2007; 7 March [Epub ahead of print].
29. Ben Abdallah A, Scheier LM, Inciardi JA, et al. A psycho-economic model of ecstasy consumption and related consequences: a multisite study with community samples. Subst Use Misuse 2007; 42:1651-1684. This is the first study examining the relationships between economic factors, psychological factors, MDMA consumption, and MDMA use disorders.
30. Hopper JW, Su Z, Looby AR, et al. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug Alcohol Depend 2006; 85:221-235. This study provides detailed descriptions on the new methodology for studying drug use (ecological momentary assessment). This new method allows researchers to monitor drug use behaviors and craving in real time and minimize the errors from recall bias.
31. Lau JT, Thomas J. Risk behaviours of Hong Kong male residents travelling to mainland China: a potential bridge population for HIV infection. AIDS Care 2001; 13:71-81.
32. Lau JT, Thomas J, Lin CK. HIV-related behaviours among voluntary blood donors in Hong Kong. AIDS Care 2002; 14:481-492.
33. Carroll ME. Income alters the relative reinforcing effects of drug and nondrug reinforcers. Chicago: University of Chicago Press; 1999.
34. O'Brien CP, Childress AR, McLellan AT, Ehrman R. A learning model of addiction. Res Publ Assoc Res Nerv Ment Dis 1992; 70:157-177.
35. Becker GS, Murphy KM. A theory of rational addiction. J Political Econ 1988; 96:675-700.
36. Goudie AJ, Sumnall HR, Field M, et al. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug Alcohol Depend 2007; 89:107-115. An innovative study examining the effects of price and perceived quality of drugs on drug purchase. The authors provide a brief but informative theoretical account for the application of behavioral economics to drug use research.
37. Greenwald MK. Behavioral economic analysis of drug preference using multiple choice procedure data. Drug Alcohol Depend 2008; 93:103-110. The author uses an experimental paradigm (multiple choice procedures) to examine the relationships between an individual's preference for psychoactive drugs and money amounts (price).
38. Parrott AC. The psychotherapeutic potential of MDMA (3,4-methylenedioxy- methamphetamine): an evidence-based review. Psychopharmacology (Berl) 2007; 191:181-193. The author provides a systematic review on the therapeutic potential of MDMA. Owing to a lack of clear evidence for the beneficial effects of MDMA in psychotherapy, the author is skeptical about the clinical utility of MDMA.
39. Sessa B. Is there a case for MDMA-assisted psychotherapy in the UK? J Psychopharmacol 2007; 21:220-224. This review paper provides the historical background of the use of MDMA as a therapeutic tool in psychotherapy. The author also describes the recent re-emergence of scientific interest in MDMA and other psychedelic drugs.
40. Sessa B, Nutt DJ. MDMA, politics and medical research: have we thrown the baby out with the bathwater? J Psychopharmacol 2007; 21:787-791.
41. Greer G, Tolbert R. Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 1986; 18:319-327.
42. Hastings A. Some observations on MDMA experiences induced through posthypnotic suggestion. J Psychoactive Drugs 1994; 26:77-83.
43. Greer G, Tolbert R. A method of conducting therapeutic sessions with MDMA. J Psychoactive Drugs 1998; 30:371-379.
44. Bouso JC. Using MDMA in the treatment of post traumatic stress disorder. In: Holland J, editor. Ecstasy: the complete guide. Park Street Press: Rochester, Vermont; 2001. pp. 248-261.